In vivo dual targeting of the oncogenic ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors

Article

Abstract: Background: The oncogenic ether-à-go-go-1 potassium channel (EAG1) activity and expression are neces

Palabras claves:

Breast Cancer, Eag1, Ki-67, Targeted therapy, vitamin D, Vitamin D receptor

Autores:

Avila-Chávez E., David B., Díaz L., Esparza-López J., Gamboa-Dominguez A., García-Becerra R., García-Quiroz J., Halhali A., Ibarra-Sánchez M., Javier Camacho, Larrea F., Ordaz-Rosado D., Santos-Martínez N., Villanueva O.

Fuentes:

scopus